Dare Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Dare Bioscience, Inc. (Nasdaq: DARE) on November 9, 2023. The report discloses a change in the Company's independent registered public accounting firm effective as of the filing date.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance regarding the audit firm.
Material Changes
- New Auditor: The Audit Committee approved the engagement of Haskell & White LLP ("H&W") as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
- Former Auditor: Mayer Hoffman McCann P.C. ("MHM") ceased serving as the Company's independent registered public accounting firm effective November 9, 2023. MHM had previously notified the Company of its resignation on August 4, 2023.
- Consultations: The Company confirmed no consultations with H&W regarding accounting principles or audit opinions during the two most recent fiscal years or the interim period through November 9, 2023.
- Disagreements: There were no disagreements or reportable events between the Company and MHM from December 31, 2022, through November 9, 2023.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The primary risk disclosed is the transition of the audit firm, though the Company states the change was not due to any disagreements on accounting principles or auditing scope.
Key Facts for Investor Verification
- Verify the effective date of the new auditor engagement (November 9, 2023).
- Confirm the reason for the resignation of the former auditor, Mayer Hoffman McCann P.C., as detailed in the August 10, 2023, Form 8-K.
- Review the letter from Mayer Hoffman McCann P.C. (Exhibit 16.1) to confirm their agreement with the Company's disclosures regarding the resignation.
- Note that the Company is not an emerging growth company.